NCT06336993 is a Phase 4 clinical trial of herbal compound in Low Back Pain, sponsored by Zhejiang Provincial Tongde Hospital.

Who is sponsoring NCT06336993?

NCT06336993 is sponsored by Zhejiang Provincial Tongde Hospital.

What drugs are being tested in NCT06336993?

Interventions in NCT06336993: herbal compound, Celecoxib.

What condition does NCT06336993 study?

NCT06336993 studies Low Back Pain.

Is NCT06336993 still recruiting?

NCT06336993 is currently completed. Last updated 29 March 2024.

Last reviewed 2024-03-29 · How we verify

NCT06336993

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP

Completed Phase 4 Last updated 29 March 2024

What this trial tests

Phase 4 trial testing herbal compound in Low Back Pain in 71 participants. Completed in 15 December 2023.

Timeline

1 January 2022

Primary endpoint
16 June 2023

15 December 2023

Quick facts

Lead sponsor	Zhejiang Provincial Tongde Hospital
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	71
Start date	1 January 2022
Primary completion	16 June 2023
Estimated completion	15 December 2023
Sites	1 location across China

Drugs / interventions tested

herbal compound — full drug profile →
Celecoxib (celecoxib) — full drug profile →

Conditions studied

Low Back Pain — all drugs for Low Back Pain →

Sponsor

Zhejiang Provincial Tongde Hospital

Who can join

Adults 20 to 90, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this randomized controlled trial was to explore the clinical efficacy and safety of HXTL in the treatment of NSLBP based on TCM principles and to compare the clinical outcomes of different syndromes of NSLBP with celecoxib.In this study, 80 patients with NSLBP were recruited and randomly grouped to use TCM compound and celeoxib respectively for intervention. The pain status and lumbar function use scale of patients were scored before intervention, 1 week, 2 weeks and 3 weeks after intervention, and the adverse reactions of patients after medication were recorded, and the clinical efficacy of the two groups of patients was compared finally.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Traditional Chinese herbal compound as complementary treatment for nonspecific low back pain: A randomized controlled trial.
Lao Y, Fu J, Chen Y, Xu B, et al · · 2024 · PMID 39533591 · DOI 10.1097/md.0000000000040392

Verify or expand the search:

Other trials of herbal compound

Trials testing the same drug.

NCT06636760 — Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery · NA · completed

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

NCT07526012 — Comparative Effects Of Post Isometric Relaxation Versus Active Isolated Stretch In Patients With Piriformis Syndrome · NA · recruiting
NCT07535047 — Placebo-Induced Hypoalgesia During Transcutaneous Electrical Nerve Stimulation Application in Low Back Pain · NA · recruiting
NCT07463729 — Evaluation of Stabilization Training With Biofeedback in Lumbosacral Spine Pain Syndrome · NA · recruiting
NCT07250568 — Office Program Effects on Pain, Posture, Muscle Physiology, Stress, Ergonomics, and Quality of Life in LBP Workers · NA · recruiting
NCT07467070 — Effectiveness of Pilates on Postural Correction, Core Strength and Flexibility in Younger Individuals With Non-specific · NA · recruiting

Other Zhejiang Provincial Tongde Hospital trials

Trials by the same sponsor.

NCT06898476 — Silkworm Pupa Powder Improves Dementia. · NA · recruiting
NCT06552403 — Effect of a Modified 5:2 Intermittent Fasting Diet on Population With Overweight or Obesity in China · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06336993 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhejiang Provincial Tongde Hospital
Last refreshed: 29 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06336993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing